BPC-157 treats high blood pressure AND low blood pressure, occasionally in the same rat BPC-157 rescues rats from too much nitric oxide AND too little
The primary limitation of FAERS is its dependence on voluntary adverse event reporting, which restricts its ability to comprehensively document all occurrences
BlevinsTPullmanJMalloyJYanPTaylorKSchulteisCet al
A reasonable decision should therefore be based on formulation quality, dose, tolerance, convenience, clinical purpose and individual response rather than a marketing claim that one form always wins
and currently working working towards my goal
Frosst, P., Blom, H.J., Milos, R., Goyette, P., Sheppard, C.A., Matthews, R.G., Boers, G.J.H., den Heijer, M., Kluijtmans, L.A.J., van den Heuve, L.P., Rozen, R